Characteristics | Overall (n = 133) | CVVHDF survivors (n = 105) | CVVHDF nonsurvivors (n = 28) |
---|---|---|---|
Age, year | 67 [52, 74.5] | 67 [51, 75] | 68 [59, 73.5] |
Men, n (%) | 90 (67.7) | 71 (67.6) | 19 (67.9) |
BMI, kg/m2 | 23.8 [20.3, 26.9] | 24.8 [21.1, 27.2] | 21.0 [19.1, 25.7] |
Source of ICU admission, n (%) | |||
Emergency department | 43 (32.3) | 31 (29.5) | 12 (42.9) |
Transfer from other hospitals | 19 (14.3) | 17 (16.2) | 2 (7.1) |
Post-surgery | 29 (21.8) | 26 (24.8) | 3 (10.7) |
General ward | 42 (31.6) | 31 (29.5) | 11 (39.3) |
Comorbidity, n (%) | |||
Diabetes | 41 (30.8) | 33 (31.4) | 8 (28.6) |
Hypertension | 47 (35.3) | 39 (37.1) | 8 (28.6) |
Baseline SCr, mg/dl | 0.83 [0.74, 1.09] | 0.85 [0.75, 1.29] | 0.79 [0.72, 0.87] |
SCr at CVVHDF initiation, mg/dl | 2.87 [1.66, 3.95] | 3.00 [1.66, 4.16] | 2.33 [1.66, 3.42] |
SOFA score at ICU admission | 10 [7, 13] | 9 [6, 12]* | 13 [10, 15]* |
Patient status at CVVHDF initiation | |||
SOFA score | 11 [8.5, 14] | 11 [8, 14]* | 14 [12, 17]* |
Use of ventilator, n (%) | 94 (70.7) | 67 (63.8)* | 27 (96.4)* |
Use of vasopressor(s), n (%) | 95 (71.4) | 68 (64.8)* | 27 (96.4)* |
Use of diuretic(s), n (%) | 42 (31.6) | 39 (37.1)* | 3 (10.7)* |
Possible AKI cause, n (%): | |||
Sepsis | 78 (58.6) | 56 (53.3)* | 22 (78.6)* |
Dehydration or bleeding | 43 (32.3) | 32 (30.5) | 11 (39.3) |
Heart failure | 35 (26.3) | 30 (28.6) | 5 (17.9) |
Surgery | 27 (20.3) | 26 (24.8)* | 1 (3.6)* |
Drug | 10 (7.5) | 7 (6.7) | 3 (10.7) |
Effluent flow rate of CVVHDF /BW, ml/h/kg | 22.9 [17.1, 30.7] | 22.3 [16.9, 28.7] | 26.8 [17.2, 40.8] |
Cumulative fluid balance since ICU admission, ml | 856 [54.6,3349] (range: − 5513, 21275) | 639 [20.5, 3349]* | 2229 [658, 4379]* |
Duration of CVVHDF, hour | 68 [39.5, 213] | 74 [42, 206] | 56 [27, 214] |